<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01094990</url>
  </required_header>
  <id_info>
    <org_study_id>DEX111</org_study_id>
    <secondary_id>PMK111</secondary_id>
    <nct_id>NCT01094990</nct_id>
  </id_info>
  <brief_title>Efficacy of Dexamethasone for Prevent Vomiting in Leukemic Children Who Receive Intrathecal Chemotherapy</brief_title>
  <official_title>Efficacy of Dexamethasone for The Prevention of Nausea and Vomiting Associated With Intrathecal Chemotherapy and Ketamine Sedation in Children With Leukemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHANCHAI TRAIVAREE</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phramongkutklao College of Medicine and Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Null hypothesis The proportions of vomiting are not different between dexamethasone and
      placebo in the patient after sedation with intravenous ketamine and lumbar puncture with
      intrathecal chemotherapy Alternative hypothesis The proportions of vomiting are different
      between dexamethasone and placebo in the patient after sedation with intravenous ketamine and
      lumbar puncture with intrathecal chemotherapy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Does intravenous dexamethasone 0.25 mg/kg (8 mg/m2/dose) have an effect in the reduction of
      vomiting and retching after sedation with intravenous ketamine and lumbar puncture with
      intrathecal chemotherapy comparison with placebo?
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>: To determine whether vomiting and retching associated with intravenous ketamine and intrathecal chemotherapy may be reduced by the addition of prophylactic dexamethasone</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine whether severity of the nausea after procedure may be reduced by the addition of prophylactic dexamethasone.</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Acute Leukemic Patients in Children</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>dexamethasone 0.25 mg/kg (8 mg/m2/dose) intravenous one time</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged between 2-15 years who underlying acute lymphoid or nonlymphoid leukemia
             and need to receive ketamine and intrathecal chemotherapy.

          -  Personally signed and dated informed consent and assent document indicating that the
             subject (or legally acceptable representative) has been informed of all pertinent
             aspects of the trial prior to study entry.

        Exclusion Criteria:

          -  Patients who had a known allergy to ketamine or dexamethasone.

          -  Patients who had contraindication for ketamine or dexemethasone such as hypertension,
             increased intracranial pressure or central nervous system mass lesion, major
             psychiatric , and hyperglycemia.

          -  Patients who concurrent with nausea and vomiting during that time.

          -  Patients who received ondansetron or other antiemetic before doing Procedure.

          -  Patients who received other chemotherapy before or after 24 hours.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>chanchai traivaree, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Phramongkutklao College of Medicine and Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Phramongkutklao hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phramongkutklao Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2010</study_first_submitted>
  <study_first_submitted_qc>March 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2010</study_first_posted>
  <last_update_submitted>January 9, 2012</last_update_submitted>
  <last_update_submitted_qc>January 9, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Phramongkutklao College of Medicine and Hospital</investigator_affiliation>
    <investigator_full_name>CHANCHAI TRAIVAREE</investigator_full_name>
    <investigator_title>Phramongkutklao College of Medicine and Hospital</investigator_title>
  </responsible_party>
  <keyword>crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

